Loading...
•
Sep 30, 2020
Zomedica Q3 2020 Earnings Report
Reported a net loss for the third quarter of 2020.
Key Takeaways
Zomedica reported a net loss of $5.0 million for the third quarter of 2020, or $0.01 per share, compared to a loss of $2.8 million, or $0.03 per share, for the same period in 2019. The company's cash position increased to approximately $52.0 million as of September 30, 2020.
Reported a net loss of approximately $5.0 million, or $0.01 per share for the quarter ended September 30, 2020.
Research and development expense increased by approximately $1.7 million, or 181%, compared to the same period in 2019.
General and administrative expense decreased by approximately $42,000, or 3%, compared to the same period in 2019.
Cash increased to approximately $52.0 million as of September 30, 2020.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...